The year 2026 is poised to be a pivotal year for the integration of artificial intelligence into healthcare, marked by the maturation of a new class of specialised systems known as Personal Health Large Language Models (PH-LLMs). These models represent a fundamental shift beyond general-purpose AI, moving from broad-based utility to domain-specific reliability. They are positioned to revolutionise the HealthTech landscape by acting as intelligent, reasoning engines that enhan

Nelson Advisors Partner Lloyd Price will lead the 'HealthTech M&A and IPOs Panel' at the Global Health Exhibition 2025 in Riyadh, Saudi Arabia. #GHE25 The Global Health Exhibition in Riyadh is a major event focused on healthcare innovation, investment, and transformation. It brings together global leaders from both the public and private sectors to discuss the future of healthcare.

Venture debt has emerged as a critical and purpose-built financial instrument within the dynamic and capital-intensive health technology (healthtech) sector. This report provides an analysis of its strategic role, delineating its distinct strengths, inherent weaknesses, current opportunities and future trajectory. Venture debt is defined as a specialised loan for high-growth, venture-backed startups, uniquely underwritten based on a company's ability to raise future equity ra

The health technology sector is experiencing a period of intense focus on artificial intelligence, driven by an "AI-first" narrative that has captivated investors and dominated industry discourse. This report posits that this concentrated market behaviour, characterised by an investment "gold rush," presents a profound opportunity for a contrarian business strategy. The prevailing AI narrative, much like other market frenzies, has led to a collective overvaluation of a single

The global HealthTech landscape is undergoing a profound structural transformation. A confluence of economic headwinds in mature markets, particularly in North America and a recalibration of investor sentiment away from speculative growth has positioned cross-border mergers and acquisitions (M&A) as the primary engine of strategic growth and liquidity. This report presents a detailed analysis of this new paradigm, arguing that strategic buyers, from big Pharma and health

The healthcare industry is on the cusp of a profound transformation, shifting from a traditional model of patient engagement to an increasingly automated, self-directed paradigm. Patient engagement, a cornerstone of value-based care, has historically relied on a collaborative, human-centric partnership between patients and their care teams. However, this model faces inherent limitations in scalability due to administrative burdens, staffing shortages, and the increasing compl

This report provides a comprehensive analysis of Nelson Advisors LLP, a highly specialised London-based M&A and corporate advisory firm, and its strategic role in assisting healthcare technology (HealthTech) and MedTech companies with UK market entry. A central finding is the firm's use of a "Build, Buy, Partner, Sell" framework, which transcends traditional transactional advisory. This holistic model guides clients, particularly Western European and North American compan

The MedTech M&A landscape in Europe in 2025 has shifted fundamentally, moving away from a strategy of broad asset aggregation to one of selective, high-value and strategically aligned investments. This new era of strategic selectivity is defined by a central thesis: acquirers are placing high-conviction bets on mature, innovative companies that offer a clear path to long-term growth and operational efficiency. The market, despite lingering macroeconomic uncertainties, is demo

Nelson Advisors Partner Lloyd Price invited to Judge the 'Digital Health Hub Foundation: Digital Health Awards 2025' at HLTH Event in Las Vegas, USA.

The MedTech mergers and acquisitions (M&A) landscape is undergoing a profound and irreversible transformation. The traditional playbook, which long emphasised incremental product improvements and narrowly focused acquisitions, has become largely obsolete. A new era has emerged, defined by the strategic convergence of medical technology, data intelligence, and consumer-centric care models.

Nelson Advisors specialise in mergers and acquisitions, partnerships and investments for MedTech companies in the UK, Europe and USA...

Nelson Advisors invited to judge the Fast Pitch Awards at the Healthcare Summit 2025 Nelson Advisors partners Lloyd Price and Paul...

Nelson Advisors featured in the PMLiVE article 'The digital prescription: enhancing the patient experience with technology' Nelson...

Nelson Advisors thought leadership blog 'Healthcare.Digital' has featured in the Tony Blair Institute for Global Change publication 'The NHS at a Crossroads: The App That Can Transform Britain’s Health' highlighting the scale and importance of Doctolib in the French HealthTech market.

The healthcare industry is in the midst of a profound transformation, driven by the convergence of digital platforms, a growing abundance of health data, and the analytical power of artificial intelligence (AI). This shift is not merely an incremental improvement but a fundamental re-architecture of care delivery, moving toward models that are more proactive, personalised, and efficient. The market for these technologies is expanding at an unprecedented rate, creating a clear